Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04496687 · ClinicalTrials.gov registry record

International Spontaneous Coronary Artery Dissection (SCAD) "iSCAD" Registry

A clinical trial of Spontaneous Coronary Artery Dissection, sponsored by SCAD Alliance.

Recruiting
Registry status
1,000
Enrollment target
20
Study locations

NCT04496687: Recruiting study of Spontaneous Coronary Artery Dissection, sponsored by SCAD Alliance.

NCT04496687 is a study of Spontaneous Coronary Artery Dissection that is actively recruiting participants, run by SCAD Alliance. The registered enrollment target is 1,000 participants, above the 688-participant average among 5 other Spontaneous Coronary Artery Dissection trials with a reported enrollment target (45% higher). The trial reports 20 study locations across 15 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04496687, a study of Spontaneous Coronary Artery Dissection, is actively recruiting participants, sponsored by SCAD Alliance.

RECRUITING
Registry status
1,000 participants
Enrollment target
20
Study locations

Study Summary

The aim of "iSCAD," the International Spontaneous Coronary Artery Dissection (SCAD) Registry, is to serve as an internationally collaborative, multicenter registry coordinated by an experienced and centralized coordinating center in an effort to increase the pace of participant recruitment, and thereby increase statistical power of studies related to SCAD. The ultimate goal of iSCAD Registry is to facilitate the development of best practices and clinical guidelines for preventing SCAD or its recurrence. This observational study will be prospective and retrospective in its recruitment and will collect clinical information to better understand the natural history and prognosis for SCAD.

Primary Outcome

Participant demographic, historical, clinical characteristics, and treatment data

Study Locations (20)

California

  • Cedars Sinai - Los Angeles
  • UCLA (University of California, Los Angeles) - Los Angeles
  • Kaiser Permanente Northern California - San Francisco

Missouri

  • St. Luke's Mid America - Kansas City
  • Washington University - St Louis

New Hampshire

  • Dartmouth-Hitchcock - Lebanon
  • Catholic Medical Center - Manchester

New York

  • Mount Sinai - New York
  • Columbia University Medical Center - New York

Colorado

  • University of Colorado - Aurora

Connecticut

  • Hartford Hospital - Hartford

Florida

  • University of South Florida - Tampa

Georgia

  • Emory Healthcare System - Atlanta

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2019-03-08
Est. Completion 2025-12-31
SCAD Alliance

1 total trials

What NCT04496687 shows while recruiting

NCT04496687 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 688-participant average among 5 other Spontaneous Coronary Artery Dissection trials with a reported enrollment target (45% higher).

The record links to 1 condition, with Spontaneous Coronary Artery Dissection appearing as the primary indexed condition, and to 0 interventions.

NCT04496687 names 20 study sites across 15 states, led by California, Missouri, New Hampshire.

Frequently Asked Questions

What is clinical trial NCT04496687 about?

NCT04496687 is a clinical study titled "International Spontaneous Coronary Artery Dissection (SCAD) "iSCAD" Registry". The aim of "iSCAD," the International Spontaneous Coronary Artery Dissection (SCAD) Registry, is to serve as an internationally collaborative, multicenter registry coordinated by an experienced and centralized coordinating center in an effort to increase the pace of participant recruitment, and ther...

What is the current status of trial NCT04496687?

This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2019-03-08. Estimated completion is 2025-12-31.

What conditions does trial NCT04496687 study?

This clinical trial studies the following conditions: Spontaneous Coronary Artery Dissection.

Who is sponsoring clinical trial NCT04496687?

This trial is sponsored by SCAD Alliance, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04496687 being conducted?

This trial has 20 study locations across California, Colorado, Connecticut, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spontaneous Coronary Artery Dissection

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00018044 · 1,000 participants

    Study of Mycobacterial Infections

  • NCT01036581 · 1,000 participants · NA

    Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging

  • NCT01192048 · 1,000 participants

    Genetics of Congenital Heart Disease

  • NCT01553214 · 1,000 participants · Phase 4

    Improving White Blood Cell Collection From Healthy Donors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04496687, the US trial registry maintained by the National Library of Medicine. NCT04496687 (large enrollment · wide site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.